Peer-Reviewed Article March 7, 2020
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: The Journal of Independent Teaching and Learning
Publisher: The Independent Institute of Education • South Africa • 1818-9687 • 2519-5670
Abstract
The abstract for this publication is cataloged under the publisher's open-access repository. Access the full text via the publisher link or DOI below.